1-2 of 2
Su-Jin Shin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma

Chang Gon Kim, Nam Suk Sim, Jeong Eun Kim, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Yoon Dae Han, Sang Kyum Kim, Jee Hung Kim, Yoon Woo Koh, Inkyung Jung, Su-Jin Shin, Sun Young Rha, Jin-Hee Ahn, Hyo Song Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3225–3234.
https://doi.org/10.1158/1078-0432.CCR-22-0518
Published: 02 August 2022
View article titled, Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
Open the PDF for Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma in another window
Includes: Supplementary data
Journal Articles

EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric Cancer

Mi-Hyeon Jeong, Soo-Yeon Park, Seung-Hyun Lee, JaeSung Seo, Jung-Yoon Yoo, Seung-Ho Park, Mi Jeong Kim, SooYeon Lee, Subhin Jang, Hyo-Kyoung Choi, Jae Eun Lee, Su-Jin Shin, Kyung-Chul Choi, Jae-Ho Cheong, Ho-Geun Yoon
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (12): 3617–3629.
https://doi.org/10.1158/1078-0432.CCR-18-2959
Published: 14 June 2019
View article titled, EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric Cancer
Open the PDF for EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric Cancer in another window
Includes: Supplementary data